Compare Stocks → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:MAVCVE:MPH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMAVPioneer Municipal High Income Advantage Fund$8.10$8.05$6.37▼$8.34N/AN/A62,423 shs28,980 shsMPHMedicureC$1.20+4.3%C$1.22C$0.93▼C$1.80C$12.30M1.014,027 shs4,000 shsThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMAVPioneer Municipal High Income Advantage Fund0.00%0.00%+0.50%+0.19%+1.89%MPHMedicure0.00%+4.35%+8.11%-11.11%+9.09%CBOE shift unlocks new weekend income strategy (Ad)You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMAVPioneer Municipal High Income Advantage FundN/AN/AN/AN/AN/AN/AN/AN/AMPHMedicureN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMAVPioneer Municipal High Income Advantage FundN/AN/AN/AN/AMPHMedicureN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMAVPioneer Municipal High Income Advantage Fund$-675.71KN/AN/AN/AN/AN/AMPHMedicureC$22.94M0.54C$0.48 per share2.49C$2.10 per share0.57Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMAVPioneer Municipal High Income Advantage FundN/AN/A0.00∞N/AN/AN/AN/AN/AMPHMedicureC$1.08MC$0.0913.33∞N/A4.71%5.04%2.49%4/4/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMAVPioneer Municipal High Income Advantage Fund$0.344.20%N/AN/AN/AMPHMedicureN/AN/AN/AN/AN/ALatest MPH, MAV, ACRL, and W7L DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/4/2024MAVPioneer Municipal High Income Advantage Fundmonthly$0.03104.1%3/14/20243/15/20244/1/20242/6/2024MAVPioneer Municipal High Income Advantage FundMonthly$0.02704%2/15/20242/16/20242/29/20241/5/2024MAVPioneer Municipal High Income Advantage Fundmonthly$0.02754.1%1/18/20241/19/20241/31/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMAVPioneer Municipal High Income Advantage FundN/AN/AN/AMPHMedicure2.862.281.29OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMAVPioneer Municipal High Income Advantage FundN/AMPHMedicure23.10%Insider OwnershipCompanyInsider OwnershipMAVPioneer Municipal High Income Advantage FundN/AMPHMedicure26.99%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableMAVPioneer Municipal High Income Advantage FundN/AN/AN/ANot OptionableMPHMedicureN/A10.25 millionN/ANot OptionableMPH, MAV, ACRL, and W7L HeadlinesSourceHeadlineCharing - Weather warnings issuedbbc.com - March 21 at 2:49 PMMesquite, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - March 17 at 1:10 AMWilliams, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - March 15 at 1:31 PMPortishead - Weather warnings issuedbbc.com - March 2 at 12:14 AM2026 Tesla Roadstercaranddriver.com - February 29 at 8:36 PMZenjan, Iran - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - February 22 at 10:16 AMChelmsford - Weather warnings issuedbbc.com - February 22 at 10:16 AMBucharest, Romania - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - February 18 at 10:07 AMRedruth - Weather warnings issuedbbc.com - February 15 at 6:54 PMConnecticut, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - February 15 at 1:53 PMMaster of Public Health Outcomesuml.edu - February 1 at 12:07 AMMalay Airport, Caticlan, Philippines [ MPH / RPVE ]prokerala.com - January 30 at 1:03 PMLeven - Weather warnings issuedbbc.com - January 20 at 11:22 PMBarberton, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - January 20 at 8:21 AMBrenda Crawford-Clark, MPHwebmd.com - January 19 at 10:14 AMArvada, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - January 17 at 7:23 AMLaurel, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - January 17 at 7:23 AMSequim, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - January 12 at 2:38 PMGravesend - Weather warnings issuedbbc.com - January 10 at 9:11 AMKate Colby, MPHhealth.com - January 6 at 2:49 PMMinneapolis, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - January 1 at 2:40 PMMichelle Manzo, MPHmedscape.com - December 30 at 2:54 PMMartin Downs, MPHwebmd.com - December 30 at 9:54 AMElaine Koenig, MPHwebmd.com - December 29 at 1:37 PMMedia Sentiment Over TimeCompany DescriptionsPioneer Municipal High Income Advantage FundNYSE:MAVPioneer Municipal High Income Advantage Fund, Inc. is a closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. The fund invests in the fixed income markets of the United States. It invests primarily in municipal bonds. The fund benchmarks the performance of its portfolio against the Barclays Capital High Yield Municipal Bond Index and the Barclays Capital Municipal Bond Index. It was formerly known as Pioneer Municipal Advantage Trust. Pioneer Municipal High Income Advantage Fund, Inc. was formed on August 6, 2003 and is domiciled in the United States.MedicureCVE:MPHMedicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.